Janice K. Albrecht

35.1k citations
117 papers · 26.0k indexed · 15 hit papers · h-index 48
Topics
Hepatitis C virus research (85 papers)Liver Disease Diagnosis and Treatment (53 papers)Hepatitis B Virus Studies (38 papers)

In The Last Decade

Janice K. Albrecht

113 papers receiving 25.0k citations

Hit Papers

Peginterferon alfa-2b plus ribavirin compared with interf...19892026200120132001199819982011198910002.0k3.0k4.0k

Peers

Janice K. Albrecht
Comparison fields: 5 of 142
  • Hepatology 23.6k
  • Epidemiology 21.7k
  • Infectious Diseases 2.9k
  • Rheumatology 2.5k
  • Molecular Biology 1.2k
Replace Mitchell L. Shiffman with:
Mitchell L. Shiffman United States
Ira M. Jacobson United States
Antonio Craxı̀ Italy
Eugene R. Schiff United States
Patrick Marcellin France
Geoffrey Dusheiko United Kingdom
Harry L.A. Janssen Netherlands
Vinod K. Rustgi United States
Daniel Dhumeaux France
Frédéric Charlotte France
Janice K. Albrecht relative to Mitchell L. Shiffman United States Mitchell L. Shiffman's profile →
Citations per field
00.5×1.5×
Mitchell L. Shiffman · 1×
Citations per year

Countries citing papers authored by Janice K. Albrecht

Since Specialization
Citations

This map shows the geographic impact of Janice K. Albrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice K. Albrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice K. Albrecht more than expected).

Fields of papers citing papers by Janice K. Albrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice K. Albrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice K. Albrecht. The network helps show where Janice K. Albrecht may publish in the future.

Co-authorship network of co-authors of Janice K. Albrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Janice K. Albrecht. A scholar is included among the top collaborators of Janice K. Albrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice K. Albrecht. Janice K. Albrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 54
3 40
4 150
5 30
6
PREDICTORS OF CONSENT TO PHARMACOGENOMICS TESTING IN THE IDEAL STUDY
0
7
PREDICTING PEGINTERFERON-alpha AND RIBAVIRIN TREATMENT RESPONSE IN GENOTYPE 1 HCV PATIENTS - SIMPLE NOMOGRAMS TO SUPPORT CLINICIANS
1
8
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infectionbreakdown →
1229
9 69
10 36
11
Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis Cbreakdown →
625
12
A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis Cbreakdown →
507
13
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialbreakdown →
4843
14 297
15 22
16 68
17
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis Cbreakdown →
1070
18
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis Cbreakdown →
2818
19 16
20
A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis Bbreakdown →
664

About Janice K. Albrecht

Janice K. Albrecht is a scholar working on Hepatology, Epidemiology and Genetics, having authored 117 papers that have together received 26.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (85 papers), Liver Disease Diagnosis and Treatment (53 papers) and Hepatitis B Virus Studies (38 papers). The work is most often cited by research in Hepatology (23.6k citations), Epidemiology (21.7k citations) and Rheumatology (2.5k citations). Janice K. Albrecht has collaborated with scholars based in United States, France and Germany. Frequent co-authors include John G. McHutchison, Zachary Goodman, Stuart C. Gordon, Mitchell L. Shiffman, Michael P. Manns, Vinod K. Rustgi, Thierry Poynard, Kenneth Koury, Eugene R. Schiff and Robert Reindollar. Their work appears in journals such as Nature, New England Journal of Medicine and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026